Streetbeat News

Stock Prices

OGN

Organon's stock (OGN) is trading higher following the announcement that XACIATO 2%, a prescription medication, is now available.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:29 pm

MASI

Masimo Corporation's stock is trading higher following the company's announcement of increased EPS guidance for the fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:25 pm

DNA

Ginkgo Bioworks' stock is trading lower following the company's announcement that its preliminary unaudited Cell Engineering revenue for 2023 is expected to be within the previously disclosed guidance range of $145 – $150 million.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:24 pm

BTCUSD

SPY

A spokesperson for Cboe has stated that the exchange is awaiting SEC approval for spot Bitcoin ETFs. The SEC has yet to approve any spot Bitcoin ETFs, which would allow for direct investment in Bitcoin rather than derivatives.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:19 pm

IRBT

iRobot shares are trading lower after news that Amazon declined a settlement offer from the European Commission regarding their acquisition deal.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:15 pm

UAL

United Airlines has announced the cancellation of 167 Max 9 flights today and anticipates significant cancellations on Thursday as well. The company is awaiting final approval on the full inspection process.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:13 pm

ACRS

INCY

ROIV

Aclaris Therapeutics Inc (ACRS) reported positive Phase 2b study results for ATI-1777, a treatment for eczema, meeting the primary efficacy endpoint. William Blair acknowledged the data's positive trend but noted higher vehicle response compared to similar studies, suggesting caution and recommending waiting for more data. ACRS shares dropped 21.88% following the news. Roivant Sciences (ROIV) and Incyte Corporation (INCY) were mentioned as having competitive therapies.

Portfolio Pulse from Vandana Singh

January 10, 2024 | 8:12 pm

REBN

Reborn Coffee Inc received a notice from Nasdaq on January 4 regarding delisting or failure to satisfy continued listing rules, as per an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:12 pm

TOST

Goldman Sachs analyst Will Nance upgraded Toast Inc (TOST) to Buy with a $24 price target, citing expectations of improved profitability trends in 2024 and potential GAAP profitability in 2025. Despite negative investor sentiment due to weaker ARPU and GPV trends, Nance believes the market underestimates TOST's market share growth in its core SMB market and its software platform's competitive edge. TOST's valuation is also seen as favorable compared to software-oriented peers. TOST shares rose 2.42% to $19.25.

Portfolio Pulse from Shivani Kumaresan

January 10, 2024 | 8:06 pm

AMZN

IRBT

Shares of iRobot (IRBT) experienced a sudden drop as traders shared a post indicating that Amazon (AMZN) may not proceed with a settlement offer with the European Commission regarding its acquisition of iRobot. This development could potentially affect the completion of the deal.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:04 pm